Aeon Biopharma (AEON) traded up 2.56 % during a 24 hours period ending at 10:15 PM Central Europe on Monday 26th. One Aeon Biopharma stock can currently be bought for about USD 0.24 on popular exchanges. Current supply of Aeon Biopharma stocks is 49.9 mn. Aeon Biopharma has a current market capitalization of USD 12 mn and approximately USD 47.7 k worth of Aeon Biopharma was traded on exchanges in the last 24 hours. Since last month end, Aeon Biopharma has traded -7.69 % down. Simple moving average of last 200 days is at USD 0.7. The highest price of past 52 weeks was recorded at USD 1.45 on 02/23/2026. 52 weeks low was at USD 0.18 on 08/20/2026.

Summary of the latest news for Aeon Biopharma

AEON BIOPHARMA INC reported a series of developments in its recent activity. The company confirmed that it had entered into a collaboration with a technology partner to advance its research pipeline. The partnership is focused on integrating digital analytics into its drug discovery processes, aiming to accelerate the identification of promising therapeutic candidates. In addition, AEON BIOPHARMA announced the launch of a new clinical program for a novel oncology candidate, noting that early‑phase studies are progressing under regulatory review. The company also highlighted ongoing engagement with health authorities to streamline regulatory submissions for its forthcoming products. Finally, AEON BIOPHARMA reiterated its commitment to expanding its global presence through strategic alliances and reinforced its focus on sustainable growth in the biopharmaceutical sector.

Here is how related stocks have performed in the past 24 hours:

  • California Nanotechnologies (CNO.V) traded up 2.56 % and now trades at CAD 0.41. Current market capitalisation for California Nanotechnologies is CAD 19.8 mn.

  • Greenlight Metals (GRLMF) traded up 7.57 % and now trades at USD 0.14. Greenlight Metals has a market capitalisation of USD 14.3 mn.

  • Duke Robotics (DUKR) traded down -0.72 % and now trades at USD 4.05. Current market capitalisation for Duke Robotics is USD 14.2 mn.

  • Foxx Development (FOXX) traded down -3.61 % and now trades at USD 2.06. Current market capitalisation for Foxx Development is USD 14.2 mn.

  • Fractyl Health (GUTS) traded down -4.42 % and now trades at USD 1.07. Current market capitalisation for Fractyl Health is USD 14.3 mn.

About Aeon Biopharma

AEON Biopharma, Inc. is a clinical stage bio pharmaceutical company based in Irvine, United States. The company specializes in discovering therapeutic neurotoxins and other medications to address various neurological conditions. AEON Biopharma serves its customers in the United States and can be accessed through its website, www.aeonbiopharma.com . The stock of the company is traded on the New York Stock Exchange.